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ABSTRACT  Potential-dependent inhibition of charge movement components by 
nifedipine  was  studied  in  intact,  voltage-damped,  frog  skeletal  muscle  fibers. 
Available charge was reduced by small shifts in holding potential (from -100 mV 
to -  70 mV) in 2 #M nifedipine, without changes in the capacitance deduced from 
control (-120 mV to  -100 mV) voltage steps made at a  fully polarized (-100 
mV)  holding potential. These voltage-dependent effects did not occur in lower 
(0-0.5  ~tM) nifedipine  concentrations.  The  voltage  dependence  of membrane 
capacitance at higher (10 #M) nifedipine concentrations was reduced even in fully 
polarized  fibers,  but  shifting  the  holding voltage produced  no  further  block. 
Voltage-dependent inhibition by nifedipine was associated with a  fall in available 
charge, and a reduction in the charge and capacitance-voltage relationships and of 
late  (q,)  charging transients.  It  thus  separated  a  membrane capacitance with  a 
distinct and  steep  steady-state voltage dependence. Tetracaine (2  raM)  reduced 
voltage-dependent membrane capacitance and  nonlinear charge  more  than did 
nifedipine. However, nifedipine did not exert voltage-dependent effects on charg- 
ing currents,  membrane  capacitance,  or inactivation of tetracaine-resistant  (qa) 
charge. This excludes participation of qa, or the membrane charge as a whole, from 
the voltage-dependent effects of nifedipine. Rather, the findings suggest that the 
charge  susceptible  to  potential-dependent  block by  nifedipine  falls  within  the 
tetracaine-sensitive (q,) category of intramembrane charge. 
INTRODUCTION 
There has been recent interest in receptors for 1,4-dihydropyridine calcium channel 
antagonists in skeletal muscle membrane in connection with possible roles as voltage 
sensors regulating excitation-contraction coupling. The latter process may depend 
on an interaction between the  transverse  tubular membrane, which produces the 
primary triggering electrical change, and junctional sarcoplasmic reticulum, where 
Ca  ~+ is stored and released. It is likely that such coupling occurs at "triad" or other 
specialized junctional regions where the two membrane systems are closely opposed 
(Franzini-Armstrong,  1970; Franzini-Armstrong and Nunzi,  1983;  Ferguson et al., 
1984).  Thus,  through  its  specific ryanodine binding,  a  Ca  2+  release  channel  was 
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localized  to the junctional feet linking the transverse tubules to terminal cisternal 
regions of sarcoplasmic reticulum.  (Fleischer  et al.,  1985;  Campbell et al.,  1987; 
Imagawa et al., 1987; Inui et al., 1987; Lai et al., 1987; Lai et al., 1988). Conversely, 
dihydropyridine receptors are abundant in transverse tubular membrane (Fosset et 
al., 1983), and have been localized to the triad structures (Leung et al., 1987,  1988), 
from which they have been isolated as proteins (Curtis and Caterall, 1984; Borsotto 
et al.,  1985;  Flockerzi et al.,  1986). Ca  2+ antagonists modified contractile activation 
in  a  manner  parallel  to  changes  produced  by  Ca  2+  deprivation  (Luttgau  and 
Spiecker,  1979;  Luttgau et al.,  1986,  1987).  Taken with ultrastructural evidence 
suggesting direct interactions between transverse tubular and junctional sarcoplas- 
mic  reticular elements (Kawamoto et al.,  1986;  Block et al.,  1988),  these findings 
make  a  mechanical coupling hypothesis at  the  triadic junction  (Chandler et  al., 
1976), involving dihydropyridine receptors as voltage sensors, an attractive possibil- 
ity (see also Schwartz et al., 1985). 
It has been suggested that intramembrane charge movements in skeletal  muscle 
could  reflect  the  voltage  sensing  step  in  contractile  activation  (Schneider  and 
Chandler, 1973). Subsequently, studies in intact muscle fibers resolved this nonlinear 
charge into distinct components (Adrian and Peres, 1979). Of these, the tetracaine- 
sensitive  (q~) species  had a  voltage dependence, and kinetic and pharmacological 
properties consistent with a regulatory role in contractile activation (Huang, 1981, 
1982,  1983;  Vergara and Caputo,  1982;  Hui,  1983;  Adrian and Huang,  1984a). 
Additionally, recent reports  suggested that q, charge movements occur indepen- 
dently of transitions in the qa charge (Adrian and Huang, 1984b; Huang, 1987) and 
can be exclusively localized to transverse tubule membranes (Huang and Peachey, 
1989).  The latter finding strongly suggests  that the q-r charge is causally related to 
initiation of contractile activation, although it need not exclude that fraction of qa 
existing in the tubules from this process. 
Recently it  has  been  reported  that  dihydropyridines also  influence nonlinear 
charge (Lamb, 1986;  Rios and Brum, 1987). These agents modify both contractile 
activation and calcium channel gating (Almers and Palade, 1981), but under different 
conditions (cf.  McCleskey,  1985).  Charge  movements influenced by such  agents 
might therefore be implicated in either or both of these processes.  However, of 
particular  interest  was  that  fraction  of the  intramembrane  charge  inhibited  by 
shifting the holding voltage from -  100 mV to -  70 mV in the presence of nifedipine 
in cut fibers. This inhibition was accompanied by a reduction, even if not abolition of 
the A[Ca  2+]  signal  (Rios and Brum,  1987).  At least this portion of the nonlinear 
charge,  inhibited when the double conditions of shifted holding voltage and the 
presence  of nifedipine was  satisfied,  could accordingly be  related  to  contractile 
activation. The earlier report did not discriminate whether the charge concerned 
corresponded to particular qa or q~ components or was drawn from the nonlinear 
charge  as  a  whole.  The  experiments here  accordingly first separate  the voltage- 
dependent effects of nifedipine in intact fibers, and then examine for correspon- 
dence between such nifedipine and voltage-sensitive  charge, and the earlier resolu- 
tion of charge movement components (Adrian and Peres, 1979;  Huang, 1981;  Hui, 
1983).  Some of the experiments accordingly used a  pulse procedure using small 
voltage steps (Adrian and Peres,  1979)  to yield a description of membrane capaci- HUANG  Charge Movement Components in Nifedipine  537 
tance rather than  total charge, as a  function of voltage. This approach emphasized 
steeply voltage-dependent effects  and  so was  used,  in  combination with  a  voltage 
clamp of intact fibers, to separate and emphasize the features of q.rcharge on earlier 
occasions (Huang,  1982). 
METHODS 
Frog  (Rana  temporar/a)  sartorius  muscles  were  dissected  in  Ringer  solution  at  4"C  and 
mounted  in  a  temperature-controlled recording chamber.  The  bathing solution was  then 
altered to a hypertonic, tetraethylammonium-containing solution (see below). The muscle was 
stretched such that the fibers had a center sarcomere length of 2.2-2.4 #m measured with an 
eyepiece graticule with  a  x40  water immersion objective (Zeiss, Oberkochen,  FRG),  and 
studied at 3.5-4.2~  The pelvic end of the muscle fibers was subject to a three-microelectrode 
voltage clamp  procedure  described  more  fully elsewhere  (Adrian  and  Almers,  1976a,  b; 
Adrian, 1978; Adrian and Rakowski, 1978). Only superficial fibers on the inner surface of the 
muscle directly accessible to the bathing solution were studied. Conventional glass microelec- 
trodes, of 4-10  MOhm  resistance, were positioned at standard distances of •  ---- 375  #m 
(voltage control electrode V0, 2Q  ---- 750 #m (second voltage electrode, V2) and 5f/2  ---- 875 
~m  (current  injection electrode I0),  respectively, from  the  pelvic end  of the  fiber,  unless 
otherwise stated. The bathing solution was then again replaced by one of the test solutions 
containing nifedipine, before electrode insertion. The voltage electrodes contained 3 M KCI, 
and the current electrode contained 2 M K citrate. 
Membrane potential was first held at -100 mV, and linear membrane and cable constants 
determined using 20-mV depolarizing control steps of 124 ms duration, imposed 500 ms after 
a prepulse from the -  100-mV holding potential to a  -  120-mV conditioning potential. In the 
course  of each experiment, when  obtaining repeat control records, holding potential was 
returned  to  -100  mV  and  the  same  control  pulse procedure adopted whatever the  test 
protocol. This ensured constant control conditions and avoided discrepandes that could arise 
in the amounts of control charge owing to possible charge interconversion (Brum and Rios, 
1987).  In addition, a  set of control experiments were performed expressly to investigate for 
variations in the control capacitance under the different conditions. First, the capacitance as 
determined by a + 20-mV voltage step to -  100 mV was investigated in 2 t~M nifedipine before 
and during charge inactivation by shifts in holding voltage, as well as after restoration of the 
holding voltage to -  100 inV. Second, successive values of control capacitance that were used 
to bracket records of test transients were followed to examine for any systematic change in 
these values. These findings are considered in the Results. 
The length constant, X, internal longitudinal resistance, ri, and membrane resistance of unit 
fiber length rm, were calculated from steady values of V,(t),  V2(t  ) and injected current Io(t ) at 
the  end  of the  20-mV  step.  Fiber diameter d  and  specific membrane  resistance R m were 
determined using a value of the internal sarcoplasmic resistivity R i of 391  Ohm cm in 2.5x 
hypertonic solution at 2~  assuming a  Ql0 of 0.73  (Hodgkin and Nakajima,  1972).  Fibers 
studied were  selected to  have  diameters  between  60  and  110  #m.  Fiber cable constants 
accordingly were comparable between experimental groups and are summarized in the figure 
legends. The membrane current through unit area of fiber surface, I~,(t) was computed as: 
Ira(t) =  [VI(/) -  V2(t)]d/(612Ri), 
where  t  is  time.  The  capacitative charge  moved  by  the  applied voltage  step  AVI(t)  was 
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voltage step using Simpson's rule: 
f  [Im(t) -- O/R,,)AV,(t)] dt 
(Adrian and Almers,  1974;  Adrian,  1978).  In control steps, these integrals and calculated 
values  of  the  linear cable constants  were  used  to  calculate  the  effective linear electrical 
capacity, referred to unit apparent lateral fiber surface area C  c ~F/cm2), from both "on" and 
"off" transients. The control transients, scaled for the relative sizes of test and control voltage 
steps, were subtracted from test transients to obtain the nonlinear charge movement. Any 
significant baseline remaining after this subtraction resulting from extra ionic current in the 
test pulse, was corrected by fitting and subtracting a straight line to this baseline. 
The above computations were obtained from values representing Vl(t), V~(t)-V2(O, and Io(t) 
obtained  by  12-bit  analogue-to-digital conversion  at  a  sampling interval  of  200  ps  after 
filtering through 3-pole Butterworth filters set to a cut-off frequency of 1 kHz, and sampled 
using a PDP  11/23 computer (Digital Equipment Corporation, Maynard, MA) with a model 
502 interface (Cambridge Electronic Design, Cambridge, UK). Five sweeps were averaged in 
each  record,  whether  test  or  control,  in  the  course  of any given  pulse  procedure  when 
obtaining steady-state quantities of capacitative charge. When obtaining records for display of 
transients, 8-10  sweeps were averaged into each record. Sets of five determinations of test 
records were bracketed by determinations of control records. This additionally monitored 
fiber stability and condition. Successive bracketing control records were used as controls for 
the intervening test pulses when deducing nonlinear charge movements. In addition, the first 
test record in the following bracket was obtained using the same pulse procedure as the last 
test pulse in the bracket before. This made it possible to monitor the stability of nonlinear as 
well as linear membrane properties in the course of each experiment. 
Electrical recordings  were  made  at  3-4~  in  tetraethylammonium-containing solutions 
similar to one used in earlier work (e.g., Adrian and Peres, 1979; Huang, 1982), consisting of 
80  mM  tetraethylammonium  sulphate,  15  mM  tetraethylammonium  chloride,  2.5  mM 
Rb2SO  4, 8  mM  CaSO  4, 350  mM sucrose, and 3  mM  HEPES buffered to pH 7.  Nifedipine 
stock solutions were freshly made in absolute ethanol for each experiment to a concentration 
adjusted for addition to test solution to result in a constant dilution of ethanol, whatever the 
intended nifedipine concentration (including bathing solutions not containing nifedipine), and 
protected from light. The test solution was introduced after electrode positioning over any 
given fiber but immediately before impalement. 
RESULTS 
Control Membrane Capacitances 
When  deriving charge  movements,  test  transients  were  compared  with  those  ob- 
tained under control pulses, which used voltage steps between the fixed membrane 
potentials  of  -120  and  -100  mV.  Where  the  holding  voltage  was  varied  in 
preceding  test  procedures,  it  was  then  returned  to  a  level  of  -100  mV  before 
imposing the control pulses. This was to allow any charge interconversion that may 
have  occurred  to reverse  (Brum  and  Rios,  1987),  in order  to  ensure  a  consistent 
reference record with which to compare test transients to obtain the relative charge 
movements. This latter point was empirically confirmed by a  set of experiments that 
additionally investigated for variations in control capacitance at the altered holding 
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First, capacitances were  deduced  from transients  in  response  to control voltage 
steps at a  holding voltage of  -  100  mV,  in  2  #M  nifedipine,  the  concentration  at 
which  voltage-dependent  inactivation was  demonstrated  as  described  below.  This 
result was compared with similar determinations of control capacitance using pulses 
involving the  same voltage excursion,  when  charge  was  inactivated by altering the 
holding voltage from  -100  mV to  -70  mV, and then to  -50  mV, respectively, as 
well  as  after  returning  the  holding  level  to  -100  mV.  Charging  records  were 
obtained at both 60 and 90 s after each change in holding potential, to confirm that 
stable readings were  obtained.  Fig.  1  displays the total capacity transient  obtained 
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FIGURE 1.  Investigation of membrane capacitance deduced by voltage steps from a prepulse 
voltage of -120  mV to  -100  mV,  in fibers held at  -100  mV,  showing the total capacity 
transient (A). This was used in subtractions to give difference traces 90  s after the holding 
voltage was shifted to  -  70 mV (B),  -  50 mV (C), and finally back to  -  100 mV in the same 
fiber (D). The difference traces are shown at a high gain similar to that used in the remaining 
figures.  E,  Steady-state  capacitances  (mean  _+  SEM)  at  the  different  holding  voltages, 
normalized to the initial result in the same fiber as obtained in A. Remaining cable constants: 
temperature =  4.9~  R+ =  325.32 ~ cm, ~  =  2.2  +  0.41  ram, r i =  11,905  +  1,899 k~/cm, 
diameter =  61.4  _+ 4.9 vm, r m =  547.4  _+  130.4 kfl cm, Rm =  11.09  + 3.4 kfl cm  2. 
initially at a  holding potential of  -100  mV  in one  such  experiment  (A). This was 
subtracted from transients obtained at holding potentials of -70  mV (B),  -50  mV 
(C), and after return of the holding voltage back to  -  100 mV, respectively (D). The 
subtraction records are displayed (Fig. 1, B-D) at a high magnification similar to that 
used in the later figures. Such traces would demonstrate alterations in the response 
of the membrane capacitance to a  control step with changes in holding potential or 
with a  history of such  changes.  However,  subtractions were  flat not only after the 
final return of the holding voltage but at the altered holding levels as well. 540  THE JOURNAL  OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  96  ￿9  1990 
Fig.  1 E goes on to plot steady-state membrane capacitances obtained by integrat- 
ing the transients  (Adrian and Almers,  1974).  These are normalized to the initial 
capacitances at the outset of the experiment in each of four fibers. This confirms 
little change in steady-state capacitance with mean (-+ SE of the mean) ratios close to 
1.0  throughout.  Thus  records from a  control step at  -100mV  offered consistent 
control comparisons for both transients as well as steady-state results obtained at test 
potentials. 
Second,  as  indicated  in  the  Methods,  in  all  experiments,  including  those  that 
explored  the  effect of holding  potential,  sets  of test  records  were  bracketed  at 
regular intervals by control records obtained with the holding potential returned to 
its initial  (- 100  mV)  holding value.  It was therefore possible to follow, and so to 
detect, any systematic changes in successive sets of control records that might be the 
result of any interconversion processes failing to reverse. The ratios of capacitances 
obtained at the end of each experiment to that at  the outset of each experiment 
before holding voltage was altered (and whose detailed cable constants are given in 
the legend to Fig. 4) are given below: 
(a)  Fibers in 0 uM nifedipine: 1.023  -+ 0.066 (n  =  5 fibers). 
(b)  Fibers in 0.5 #M nifedipine: 0.994  +  0.189 (n  =  4). 
(c)  Fibers in 2 ~M nifedipine: 1.007  +  0.088 (n  =  6). 
(d)  Fibers in  10 #M nifedipine: 0.973  _+  0.154 (n =  4). 
They indicate no significant change  (P >>  5% on t  testing) in the values of control 
capacitance through an experiment in the fibers discussed here. 
Thus, at any given nifedipine concentration, it is possible to provide a consistent 
control  steady-state  capacitance  for  comparison  of results  even  through  varying 
holding levels. This made it possible to investigate the voltage-dependent effects of 
nifedipine, to which attention here is primarily directed, even without requiring that 
control capacitances  obtained in  different pharmacological conditions are  compa- 
rable. 
Voltage-dependent Effects of Nifedipine  in Intact Fibers 
The experiments here sought to investigate potential-dependent block by nifedipine 
in  intact  muscle fibers,  using  the  technique used  earlier to demonstrate  different 
charge  movement  components  (Adrian  and  Peres,  1979;  Huang,  1982).  This 
complemented  the  earlier  studies,  which  used  cut  fibers  (Lamb,  1986;  Rios  and 
Brum,  1987)  but which  did not examine for effects on individual  charge species. 
Accordingly, the experiments first simply attempted to demonstrate such potential- 
dependent effects of nifedipine in intact fibers (Fig. 2). They applied single test steps 
to a range of membrane potentials chosen in 10-mV increments from the -  100-mV 
holding voltage in parallel with the cut fiber study. 
It was possible to demonstrate charge susceptibility to voltage-dependent block in 
intact fibers, but this required nifedipine concentrations of 2 #M, in contrast to the 
considerably  lower  levels  (0.5  #M)  used  in  cut  fibers.  Effects  of  varying  drug 
concentrations are  discussed further below.  Nonlinear charge in  2  #M  nifedipine 
increased with depolarization at a  holding potential of -100  mV, as described on 
earlier occasions (Schneider and Chandler,  1973).  For example, in  Fig.  2 A,  large 
depolarizations  to  test  potentials  of  -20  mV  moved  over  30  nC/#F  of charge. HUANG  Charge  Movement Components in Nifedipine  541 
Charge  movements  (Fig.  2 B)  were  monotonic  decays  showing  no  clear  kinetic 
evidence of hump components even in "on" responses. This is in agreement with 
earlier contrasts made between cut and intact fibers. Thus earlier work (e.g., Adrian 
and Peres,  1979)  reports  that  q, gives delayed currents only at  a  defined voltage 
range near the mechanical threshold, and these transients merge with the rest of the 
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FIGURE 2.  Steady-state charge 
(A) and charge movements ob- 
tained  in  response  to  large 
voltage steps  from  -100  mV 
to  different voltages  V in the 
presence of 2 #M nifedipine, at 
holding potentials V. of -  100 
mV  (B;  circles)  and  -70  mV 
(C; triangles) in the same fiber. 
Alternate traces are labeled; re- 
spective  records  in  B  and  C 
correspond  to  the  same  volt- 
age.  Charge inactivated by the 
holding  potential  change  (A; 
squares) was obtained from the 
difference between the two sets 
of values. Fiber R44; tempera- 
ture =  3.5~  fiber cable con- 
stants: R i =  340 Q cm, X =  2.5 
mm, r i =  6,188 kfl/cm, diame- 
ter  =  83.6 #m, r m =  390  kfl 
cm, R m =  10.25 kft cm  ~, Cm = 
6.07 #F/cm  2. 
decay with further depolarization, and even then were easiest demonstrated with a 
pulse procedure using small (see below) rather than large steps, first adopted here. 
The test pulses were then repeated at a  holding voltage of -70  mV with repeat 
control records still taken at a holding voltage returned to  -100  mV (see Methods). 
Charge  movement records were then obtained in the same fiber. This applies not 542  THE JOURNAL OF  GENERAL  PHYSIOLOGY. VOLUME  96.  1990 
only to Fig.  2  but all the figures to follow, which display charge movement records 
obtained before and after voltage-dependent inactivation in nifedipine in the same 
fiber.  Maximum available charge was  now reduced:  the  charge  moved by a  pulse 
from -  100 mV to -20  mV fell from 25.1  + 0.4 to 19.8  _  1.3 nC/#F (mean _+ SEM) 
in five fibers. Altering holding voltage not only modified the amount of charge but 
also altered the form of the charge-voltage curve.  For example, steady-state charge 
changed  little  with  small voltage  steps;  the  major  reduction  occurred  with  larger 
pulses  beyond  approximately  -50  inV.  The  amount  of  inactivated  charge  was 
deduced  by comparing data  points  at  holding voltages of  -100  mV  (circles)  and 
-70  mV  (triangles;  Fig.  2 A),  respectively.  This  yielded  a  voltage  dependence 
(squares) considerably steeper than either of its originating functions, rising sharply 
at -  50 mV and approaching saturation close to -  30 mV. These steady-state findings 
were  reflected  in  the  charge  movement  being  reduced  in  comparison  to  the 
transients  obtained  in  fully  polarized  fibers.  This  occurred  particularly  at  large 
depolarizations  beyond  approximately  -50  mV,  but  not  at  smaller voltage  steps. 
Again,  charge  movements were  relatively simple  decays:  delayed  (%)  components 
were not distinct with the single test pulses applied here. 
Higher (10 #M) nifedipine concentrations caused partial charge inactivation even 
in  fully  polarized  fibers  in  agreement  with  findings  in  mammalian  fibers  (Lamb, 
1986).  Charge  movements  in  response  to  large  (-100  to  -20  mV)  steps  in 
voltage-clamped  fibers  using  a  reduced  electrode  spacing  (~  =  250  tam)  were 
obtained before and  after the  same fiber was subject  to a  solution  change  to one 
containing  10  taM  nifedipine.  Control  capacitances  before  and  after  adding  drug 
were similar (within  0.03  of the value before adding drug).  Fig 3 E, which  uses as 
control the transient obtained before drug was added, shows that  10 taM nifedipine 
reduced the size of the charging transients. 
Nifedipine Modifies Charge Inactivation 
The  voltage-dependent  effects of nifedipine  in  intact  fibers appeared  to  reflect  a 
modification  of charge inactivation.  Such  a  notion  would  predict  a  relative  fall  in 
available charge as  holding voltage was altered,  at  the  effective concentrations  of 
nifedipine.  The  experiments  here  sought  primarily  to  examine  that  fraction  of 
nonlinear charge that was inhibited when the double conditions of altered holding 
potential  and  presence  of  nifedipine  were  met.  It  was  therefore  important  to 
examine  the  effect of varying the  holding potential  at  different  concentrations  of 
nifedipine. 
In such experiments the test steps were made from a constant prepulse voltage of 
100 mV to a fixed test potential of -20  mV; this covers the range through which 
the  phenomena  outlined  in  Fig.  2  reached  saturation.  The  pulse  procedure  was 
applied  at  least  30  s  after  each  shift  in  holding  voltage  (cf.  Bruin  et  al.,  1988). 
Holding  voltages  were  examined  particularly  through  -100  mV  and  -70  mV, 
where the voltage-dependent inhibition was observed. 
Fig.  3, A-D  plots charge  so obtained,  normalized  to  available linear  membrane 
capacitance (means  _+ SEM) in the same fiber against holding potential, on separate 
ordinates. This was primarily to illustrate relative changes in available charge, using 
control voltage steps to  -  100  mV, which provided a consistent reference charge as HUANG  Charge  Movement Components in Nifedipine  543 
described in the control experiments above, provided comparisons of absolute values 
were  not  made  between  pharmacological  groups  of  fibers.  The  fiber  sets  bad 
comparable cable constants (Fig. 3, legend), and external solutions were similar apart 
from the different nifedipine concentrations. 
When nifedipine was absent (Fig. 3 A), or at low concentrations (0.5 #M; Fig. 3  B), 
a change in holding voltage from -  100 mV to -  70 mV did not produce a significant 
alteration in relative available charge; the values fell -26 nC/#F, in agreement with 
earlier reports (e.g., Huang,  1982; Hui,  1983). However, maximum charge did fall 
significantly when the holding voltage was depolarized beyond -  50 mV or -  40 inV. 
In  contrast,  with  2  #M  nifedipine  even  small  changes  in  holding  potential 
noticeably inactivated available charge. For example, a shift from -100  mV to -70 
mV reduced overall charge by ~5 nC/#F (Fig. 3 C). This was in contrast to Fig. 3, A 
and B.  Further inactivation took place at larger depolarizations.  However, charge 
inactivation also  took place  in  the  lower nifedipine concentrations at  these  latter 
holding voltages, at which it would consequendy be more difficult to attribute charge 
inactivation  solely to  a  combination  of nifedipine  and  holding  potential  change. 
Finally,  further  increasing  nifedipine  concentration  fivefold (to  10  #M)  reduced 
available  charge  even  in  fully polarized  fibers,  but  shifting the  holding potential 
(from -100  mV to  -70  mV) now did not produce further inactivation (Fig. 3 D). 
This would suggest that an increased nifedipine concentration might substitute for a 
combination  of nifedipine  treatment  and  altered  holding  voltage.  However,  this 
would then mask attempts to investigate the properties of charge whose inactivation 
by nifedipine was voltage dependent. 
As the experiments here were particularly concerned with holding potential shifts 
between  -100  mV and  -70  mV  in nifedipine,  more heavily averaged transients 
were obtained at these voltages. Their features corroborated the steady-state results. 
Fig.  3,  F-H shows  pairs  of records  from one  fiber in  each experimental group. 
Charge movements were simple decays, as expected at such test depolarizations (Rios 
and Brum, 1987). At 0.5 #M nifedipine the transient at a holding potential of -100 
mV (Fig.  3 F[a]) was  similar to that at  -70  mV (Fig.  3 F[b]).  However, in  2.0 #M 
nifedipine, changing the holding potential reduced the size of the charge movement 
(Fig. 3, G[a and b],respectively). In contrast, trangients were smaller in size in 10 #M 
nifedipine even at a holding potential of -100  mV (Fig. 3 E[a and b] and H[a]), but 
altering the holding potential to -  70 mV (Fig. 3 H[b]) now did not further alter the 
charging currents. 
These  findings  might  be  interpreted  most  simply in  terms  of the  presence  or 
absence of relative changes in available charge under each pharmacological condi- 
tion.  At low (0.5  #M)  or zero nifedipine, there was  little or no significant charge 
inactivation when  holding voltage was  altered  from  -100  mV  to  -70  mV.  This 
agrees with earlier findings in intact fibers (Huang,  1981; Hui, 1983), although cut 
fibers do show inactivation under such conditions (Rios and Brum, 1987). Therefore, 
the present findings suggest that the contrasting changes in 2 #M nifedipine, with a 
-100  mV  to  -70  mV  shift  in  holding  potential  was  entirely  due  to  charge 
susceptible to a combination of nifedipine treatment and a shift in holding potential. 
Under  such  conditions  the  degree of charge inactivation was  comparable  to  the 
effect shown  in  Fig.  2.  Larger depolarization caused further inactivation in  2  #M ,
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nifedipine, but did so in 0  #M nifedipine as well. Therefore, it would not be possible 
to exclude an influence of charge inactivation alone. Similarly, increasing the dose of 
nifedipine to  10 #M reduced available charge, but there was now no further charge 
inactivation with small shifts in holding potential. 
Nifedipine-inactivated  Charge Is Steeply  Voltage Sensitive 
The findings above suggested that a combination of 2 #M nifedipine and a  -  100 mV 
to  -70  mV  shift  in holding voltage would  sample  a  component  of the  nonlinear 
charge  whose  inactivation would  require  both  nifedipine treatment  and  a  shift  in 
holding  voltage.  It  may  not  inactivate  all  this  charge,  for  reasons  given  in  the 
previous  section,  but  nevertheless  it would  remain  possible  to  explore  its  voltage 
dependence.  These conditions were therefore  adopted when examining the voltage 
dependence  of such charge. This employed a procedure using small 10-mV test steps 
to  a  range of voltages superimposed  500  ms after large  conditioning prepulses,  as 
used  on  earlier  occasions  to  demonstrate  charge  movement  components  (Huang, 
1981). To corroborate  the experiments above, nifedipine was employed at the same 
three  concentrations  (0.5,  2,  and  10  #M)  while  examining the  effect  of  shifts  in 
holding  voltage.  Steady-state  membrane  capacitances  at  each  test  voltage  were 
normalized  to  control  values obtained  at  the  -100-mV  reference  voltage,  CT/C  c 
(plotted mean  +  SEM). This approach gives a  function more sensitive to changes in 
the  dependence  of nonlinear charge  on  membrane  potential  than  charge-voltage 
(Q(V))  curves  (Adrian  and  Peres,  1979).  As  indicated  above,  values  of  C c  were 
consistent  at  any  given  pharmacological  condition,  but  quantitative  comparisons 
were not made between fibers where the nifedipine concentrations were different. 
FIGURE 3  (opposite).  Available charge  Q~** assessed  from  the  charge  transferred  by large 
voltage steps from  -100  mV to  -20  mV, at different holding voltages  Vn and nifedipine 
concentrations of 0  #M  (A),  0.5  tam  (B),  2  taM  (C), and  10  taM  (D).  Value of zero charge 
obtained in each group arrowed with the corresponding symbol on the ordinate. In this and 
subsequent figures points with error bars indicate mean  _+  SEM. E, Charge movements in 
response to a step from -  100 mV holding potential to -20  mV before and after adding 10 
taM nifedipine. Control capacitances before and after the solution changes were 5.08 and 5.02 
taF/cm  ~,  respectively. F-H,  Pairs of charge movements obtained, in the same fiber in each 
case, in response to large voltage steps at holding potentials of -  100 mV (a) and -  70 mV (b) 
compared  in  examples  of  fibers  in  0.5  tam  (F),  2  taM  (G),  and  10  tam  (H)  nifedipine, 
respectively. Inactivation curves were assessed at nifedipine concentrations of: (A) 0 taM (tilted 
triangles, five fibers; temperature =  3.9 •  0.07"C; R i =  336 •  0.8 fl cm, X =  2.5 +- 0.11 mm, 
r~  =  8,471  •  1,178 kfl/cm, diameter  =  74.4  •  5.3 tam, r m =  519.7  •  58.4 k~ cm, R~ = 
11.72  +_  0.63  k~2 cm  2,  C m =  13.8  •  1.52  taF/cm~); (B)  0.5  taM  (open circles; four fibers; 
temperature  =  3.7~  R i =  337.9 fl cm, ~, =  3.4  •  0.64 mm, r i =  12,946  _+ 5,756 kfl/cm, 
diameter  =  74.0  •  12.7 tam,  r m =  887  •  50.4 kf~ cm, R m =  20.68  •  4.38 kfl cm  2,  C  m = 
9.06 •  1.01 taF/cm~); (C) 2.0 taM (filled circles; six fibers; temperature =  4.05 •  0.27~  R~ = 
332.8  •  3.9 fl cm, A =  3.76  •  0.17 mm, r i =  5754.3  •  1,082.8 kfl/cm, diameter =  90.8  • 
6.8 tam, r m =  792.3  •  116.1 kt2 cm, R  m  =  21.31  •  1.81 k~2 cm  2, Cm =  9.19 _+ 0.398 taF/cm2); 
and (D) 10 taM (inverted triangles, four fibers; temperature =  4.7 _+ 0.09~  R~ =  327.6  _+ 0.9 
cm,  A  =  2.81  -+ 0.09 mm, r i =  8,165  _+  1,481  k~2/cm, diameter =  77.03  •  9.84 tam, r m = 
508.4  _+  100.7 kfl cm, R m =  11.52  ___  1.54 kfl cm  ~, C  m =  11.72  •  1.14 #F/cm2), respectively. 546  THE  JOURNAL OF  GENERAL PHYSIOLOGY-VOLUME  96  ￿9 1990 
At low (0.5 #M) nifedipine concentrations (Fig.  4 A) capacitance increased gradu- 
ally  with  depolarization  to  around  -60  mV,  ~20%  above  the  reference  value 
at  -100  inV.  It then increased  steeply to  >1.6  times the control value,  at  a  test 
voltage of  -40  mV,  before falling with  charge  saturation.  However, altering  the 
holding voltage  to  -70  mV  and  repeating measurements  in  the  same  fiber  (but 
continuing  to  take  control  records  at  a  holding  voltage  of  -100  mV)  did  not 
significantly alter the capacitance-voltage relationship. Thus, at such concentrations 
there is no contribution by voltage-dependent block to the influence of nifedipine. 
This complements the inactivation results described above. 
At 2  t~M nifedipine there remained the steep dependence of membrane capaci- 
tance on voltage, and  this  was  similar  to that  obtained in  0.5  /zM  nifedipine at  a 
holding potential of -  100 mV (Fig. 4 B). However, obtaining test steps at a holding 
voltage of -  70 mV (but still  taking control steps at a  -  100 mV holding potential) 
now reduced the maximum capacitance, and altered not only the magnitude but also 
the form of the capacitance curve. Thus, the reduced dependence of capacitance on 
test voltage at a  holding potential of -70  mV did not merely represent a  simple 
scaling down of the  corresponding function in  fully polarized fibers.  Shifting the 
holding potential had little effect on membrane capacitance between test voltages of 
-100  mV and  -60  mV.  However, capacitance was substantially reduced at larger 
depolarizations giving a more gradual capacitance-voltage relationship, rising to not 
more than 1.4 times the control value before falling with charge saturation. 
Finally, 10 uM nifedipine (Fig.  4 C) reduced membrane capacitance. Even in fully 
polarized fibers, this rose to not more than 1.4 times its reference value. However, 
shifting holding voltage now caused  no further change  in capacitance,  in  parallel 
with results from the previous procedures. 
The corresponding changes  in charge movement records preferentially affected 
delayed (q~) currents rather than reducing the currents over their entire time course. 
For example, slow charge movement components (Fig. 4 D; horizontal bars) could be 
demonstrated in 2 #M nifedipine at a  -  100 mV holding voltage. In agreement with 
earlier reports  (e.g.,  Adrian  and  Peres,  1979),  they were  readily visible using  the 
pulse procedure employing small 10-mV steps, but over only a narrow voltage range 
(-40 to -30 mV) closely incremented about the normal contractile threshold. Their 
time course was initially prolonged but then became considerably more rapid and 
merged  with  the  earlier  decay  even  with  10-15  mV  further  depolarization.  In 
contrast,  altering  the  holding  potential  to  -70  mV  in  the  same  fiber  (Fig.  4 E) 
inhibited  such  slow  components,  suggesting  a  relative  preservation  of rapid  qt~ 
charge movement (Adrian and Peres, 1979; Huang, 1982; Hui, 1983). Certainly, the 
major change in transients was not a simple scaling-down of the transients at  -  100 
inV. 
These  findings  demonstrate  the  existence  and  properties  of nonlinear  charge 
inactivated by a  combination of nifedipine treatment and  altered holding voltage. 
This charge had a steep and distinct voltage dependence. Thus it was only sensitive to 
depolarization beyond about -60  mV, but its steep voltage dependence beyond this 
was responsible for the greater part of the pronounced peak in membrane capaci- 
tance at 1.6 times the control. It contributed more to late q~ transients than to the 
early qr  currents (Adrian and Peres, 1979; Huang,  1982). HUANG  Charge  Movement Components  in Nifedipine  547 
Tetracaine-resistant (qr  Charge Does Not Show Voltage-dependent Block by 
Nifedipine 
Charge  susceptible to voltage dependent nifedipine block thus showed similarities 
with the q~ charge described on earlier occasions (Huang, 1982). The q~ charge was 
defined in terms of its sensitivity to tetracaine (Huang, 1981, 1982), which conserved 
the more rapid qa transient. It was accordingly of interest to determine whether the 
charging  components  subject  to  voltage-dependent  block  by  nifedipine  demon- 
strated here fell into the category of q0 or q.~ charge, or were drawn from both qt~ 
and q~ components, i.e., from the charge as a whole. 
The  experimental  procedures  were  similar  to  those  described above, but were 
performed on  tetracaine-treated  fibers.  Fig.  5  displays  the  results  of using  large 
single pulses as used in Fig. 2 for a fiber in the presence of both 2 #M nifedipine and 
2 mM tetracaine, studied at holding voltages of -  100 mV and -  70 mV, respectively. 
Tetracaine reduced charge transfer as expected from earlier reports (Huang,  1981; 
Hui,  1983).  However, shifting the  holding potential  now did  not further reduce 
available steady-state charge (Fig.  5 A).  In addition, there was no major difference 
between charging transients before (Fig. 5 B) and after (Fig. 5 C) shifting the holding 
voltage  in  the  same  fiber.  Thus  tetracaine-resistant  (qtJ) charge  does  not  show 
voltage-dependent block by nifedipine. 
Nifedipine Does Not Modify Inactivation  of qo Charge 
Charge inactivation was next investigated in fibers using large test pulses from fixed 
prepulse levels of  -100  mV  to  a  test voltage of -20  mV.  The holding voltages 
examined were altered as described above, in successive  10-mV increments begin- 
ning with  -  100 mV.  Fig.  6 A  plots available charge against holding voltage in the 
presence of 2mM  tetracaine in fibers in both the presence and  absence of 2  #M 
nifedipine. Tetracaine reduced charge movement even in  fully polarized fibers to 
15-18  nC/#F.  This represents a  larger reduction of available charge than accom- 
plished by nifedipine alone under the conditions used here, but is in agreement with 
earlier reports (Huang,  1984). However, adding nifedipine (2 #M) did not influence 
the inactivation of such tetracaine-resistant (qr  charge. Furthermore, the same shifts 
in holding voltage that modified charge inactivation in the previous case (from -100 
mV  to  -70  mV)  produced  little  inactivation  of the  qr  system.  Fig.  6 B  displays 
examples of the corresponding charge movements in the presence of both nifedipine 
and tetracaine. In agreement with the steady-state results, they remained similar in 
size and form at both holding potentials. They were monotonic delays, and slow (q~) 
charging components were absent. 
These findings contrast with the charge inactivation by nifedipine when tetracaine 
was absent. They appear to exclude tetracaine-resistant charge from participating in 
the effect of nifedipine and implicate the tetracaine-sensitive (qT) charge. 
Nifedipine Does Not Affect the Voltage Dependence of q~ Charge 
A final procedure to exclude qt~ charge from significantly participating in nifedipine 
action compared the voltage dependence of its contribution to membrane capaci- 
tance  in  2  tiM  nifedipine  at  holding  potentials  of  -100  mV  and  -70  mV, C
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respectively.  Control  capacitance-voltage  curves  were  also  obtained  in  2  mM 
tetracaine  but  in  the  absence  of nifedipine.  As  in  the  corresponding experiments 
above, small 10-mV steps to a  series of test voltages were superimposed 500 ms after 
a  prepulse  step  (Adrian and  Peres,  1979).  Tetracaine  reduced the  dependence  of 
capacitance  on  voltage in  agreement  with  earlier work  (Fig.  7 A).  This  effect was 
more  marked  than  the voltage-dependent block by nifedipine alone.  Thus  capaci- 
tance now did not exceed 1.3 times the control value. However, 2 #M nifedipine now 
had no further influence on the capacitance-voltage function,  nor did shifting the 
holding  potential  from  -100  mV  to  -70  mV  in  the  same  fiber  produce  any 
significant change. Charge movements (Fig. 7 B) were simple monotonic decays, did 
not  show  delayed (qv) components,  and were not  significantly altered by changing 
holding potential from  -  100 mV (Fig. 7 B) to  -  70 mV (Fig. 7 C). Therefore, these 
findings also indicate  that  voltage-dependent block by nifedipine does not  involve 
tetracaine-resistant (qa) charge. 
DISCUSSION 
The experiments here explored the effects of varying nifedipine concentrations on 
charge  movements  in  intact  amphibian  muscle  fbers  with  changes  in  holding 
potential. Rios and Brum  (1987)  reported that nifedipine reduced nonlinear charge 
even in fully polarized, cut fibers. However, a  subsequent shift in holding potential 
from  -100  mV  to  -70  mV further  reduced available charge  to a  degree greater 
than  achieved  by  such  shifts  in  the  absence  of drug.  However,  the  influence  of 
nifedipine  in  fully  polarized  fibers  was  not  associated  with  a  reduction  in  Ca  ~+ 
signals.  Even  high  nifedipine  (150  #M)  concentrations  ample  to  abolish  calcium 
currents, did not influence contractile activation in fully polarized fibers (McCleskey, 
1985).  It is therefore possible that intramembrane charge, affected in fully polarized 
FIGURE 4  (0ppos/te).  Capacitance, normalized to values obtained at a  reference voltage of 
-  100 mV, CT/Co plotted against test voltage V at holding potentials of V  H =  -  100mV and 
-  70mV, respectively, and measured in each case in the same fiber. Reference capacitances for 
each fiber group marked by arrows. Three different nifedipine concentrations (0.5[A], 2[B], 
and 10 #M[C], respectively) were explored. Charge movements in response to 10-mV steps to 
the test voltage Vapplied after a 500-ms prepulse from heavier signal averaging from the same 
fiber in 2 #M nifedipine before (D) and after shifting the holding voltage from -  100 mV to 
-70  mV (E).  Fibers subject to nifedipine concentrations of (A) 0.5 #M (open circles, V  H ---- 
-100 mV; open triangles, V  H =  -70  mV), (B) 2.0 ~M (solid circles, V  n  =  -100 mV; solid 
triangles,  V  H  =  -70  mV),  and  (C)  10  #M  (inverted triangles,  V  H  ----- -100  mY;  rotated 
triangles, V  H =  -70  mV), respectively. Fiber cable constants: in 0.5 ~M nifedipine (A): four 
fibers; temperature =  3.4 •  0.08~  Ri ----  341  •  0.9 fl cm, ), =  2.0 •  0.2 mm, r i =  6,581  • 
902 kf~/cm, diameter ----  82.8  •  4.8 #m, r m =  253  •  41.8  kfl cm, R  m  ~  6.69  •  1.37  kfl cm ~, 
Cm =  7.02 •  0.42 #F/cm  ~. In 2.0 #M nifedipine (B): four fibers; temperature =  3.7 •  0.14~ 
R~ ~- 332.7  •  4.3 fl cm, ~, =  3.56  •  1.07 nun, r~ =  3,968  •  591 kfl/cm, diameter =  96.3  • 
13.82 #m, r m =  516.2  •  182.3 k~ cm, R m =  18.58  •  9.2 kfl cm  2, C  m =  10.3  •  0.64 #F/cm  ~. 
In 10 #M nifedipine (C): four fibers; temperature -- 3.9~  R i =  335.73 f~ cm, X =  3.35  • 
0.32 mm, r i =  6,368  •  887 kfl/cm, diameter ---- 84.7  •  6.68 #m, r m =  698  •  127 kfl cm, 
R  m  =  18.33  _+ 3.19 kfl cm  ~, C  m =  12.2  •  1.6 #F/cm2). 550  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  96  ￿9  1990 
fibers, is involved in calcium current gating rather than contractile activation as has 
been suggested for mammalian fibers (Lamb 1986; Lamb and Walsh, 1987). 
In contrast, a  combination of nifedipine treatment and shifts in holding potential 
did reduce (if not always abolish) Ca  2+ signals and contractile activation (Rakowski et 
A. 
it. 
=L 
20- 
10- 
O- 
Fibre  R47 
Tetracaine  2 mM 
DHP  2 uM 
O  V  H =-tOO mV 
Z~  V  H =  -70 mV 
[:3  Inactivated 
J 
(~,-.-n  []  []  G 
'  8'o  6'o  '  '  -100  -  -  -40  -20 
V(mV) 
B.  v. =-1oo  mV  2  mM  Tetracaine 
V(mV)  [\  2 pM DHP 
-2o @  ~... 
....  i: 
(. 
-80 
C.  V H--  -70  mV 
-so ~--~-~---  -~- 
-70  --~ 
50 ms 
FIGURE 5.  A, Intramembrane charge Q (v) transferred by single voltage steps from  -100 
mV to a range of test voltages V in the presence of 2 mM tetracaine and 2 t~M nifedipine at 
holding voltages of  -100  mV  (circles) and  -70  mV  (triangles). The  difference  (squares) 
indicates little inactivated charge. B and C, Charge movements obtained in the same fiber at 
the two holding voltages of -100  mV  (B) and  -70  mV (C). Alternate traces are labeled; 
respective traces in B and C correspond to the same test voltage. Fiber R47: temperature  -- 
3.9~  R~ =  335.7 fl cm, k  =  2.59 mm, r~ =  5,949 kfl/cm, diameter =  84.8 #m, r m =  397.6 
kfl cm, Rm =  10.59 kl2 cm  2, C  m =  6.68 #F/cm  z. 
al., 1987; Rios and Brum,  1987). Such a charge that was correspondingly inactivated 
then  would be of interest in connection with possible associations with contractile 
activation. The experiments here separated a  sample of the charge whose inactiva- 
tion  demanded  a  combination of both  nifedipine treatment  and  depolarization in HUANG  Charge  Movement Component~ in Nifedipine  551 
intact  fibers,  and  gained  an  indication  of  its  voltage  dependence  and  kinetic 
properties.  It  then  went  on  to  investigate whether  this  involved  the  charge  as  a 
whole, or fell withir~ one or another capacity component. Its major conclusions arise 
from comparing steady-state capacitances, using pulse procedures adopted on earlier 
occasions (Adrian and Peres,  1979;  Huang,  1981,1982)  to fractionate components 
of intramembrane charge. Such an approach enabled changes in tetracaine-sensitive 
(q,) charge to be followed even through voltages when its transients were rapid and 
not distinguishable from the qB current. 
The experiments compared test records with transients obtained by small voltage 
steps at a holding potential restored to -  100 mV. It included control experiments to 
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FIGURE 6.  A,  Charge  inacti- 
vation in  fibers in  2  mM  tet- 
racaine  in  the  absence  (trian- 
gles) and presence (circles) of 2 
#M  nifedipine.  B,  Charge 
movements  obtained  in  one 
such  fiber at holding voltages 
varied at 10-mV intervals. In 2 
mM  tetracaine:  four  fibers, 
temperature  =  4.4  +  0.1*C, 
--  330.7  +  1.3 9  cm, h  --- 
2.23  +  0.34  ram,  r i  = 
16,529  •  3,486 kg/cm, diame- 
ter =  84.47  +  6.22 #m, r~  = 
706.23  •  109.17 k9 cm, R m = 
12.31  •  2.47  kfl  cm  ~,  C  m = 
6.04  •  0.71  #F/cm  ~. In 2 mM 
tetracaine and 2 #M nifedipine: 
four  fibers,  temperature  = 
3.5"C, Ri  =  335.7  fl cm, X = 
3.45  •  0.41  ram, r i =  7,024  + 
2,592  kfl/cm,  diameter  = 
92.2  •  13.3 #m, r m =  625.4  • 
124.1  kfl cm,  R m =  16.80  • 
2.67 kfl cm  2, C  m =  6.88 :~ 0.90 
#F/crn  ~. 
confirm  that  under  any particular pharmacological condition  this  procedure  gave 
consistent reference steady-state and transient records with which to make compari- 
sons  (see,  for example,  Adrian and Almers,  1976a;  Rios and  Brum,  1987).  At all 
events,  quantitative  comparisons  of  total  charge  were  only  made  within  a  given 
pharmacological condition, in which the effect of holding voltage had been investi- 
gated in  the  same  fiber.  Quantitative  comparisons of values between  fiber groups 
subject to different drug concentrations were avoided. 
Intact fibers differed in capacitative properties from cut fibers in some respects. 
Even  in  the  absence  of nifedipine,  Rios  and  Brum  (1987)  reported  a  degree  of 
charge inactivation when holding potential was shifted from  -  100 mV to  -  70 mV. 552  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  96  ￿9  1990 
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FIGURE  7.  A, Voltage  dependence  of the  membrane capacitance  in  2  mM  tetracaine  for 
fibers in the presence of 2 #M nifedipine when studied at holding voltages of -100  mV (solid 
circles) and -  70 mV (solid triangles) in the same fiber. These are compared with fibers studied 
at 0  #M nifedipine (open triangles). Charge movements in 2  #M nifedipine obtained using a 
pulse procedure using small (10 mV) voltage steps before (B) and after (C) changing holding 
voltage in the same fiber were similar. Alternate traces are labeled; respective records in B and 
C  correspond  to  the  same  test  voltage.  Four  fibers  studied  in  2  #M  nifedipine,  2  mM 
tetracaine.  Cable constants:  temperature  =  3.7  +-  0.1~  R i  =  337.9  •  1.06  f~ cm,  X  = 
3.22  •  0.26 mm, r i  =  4,981  •  296 k.q/cm, diameter  =  93.4  •  2.7 Izm, r m =  520.6  •  76.2 
k~  cm,  R m =  15.3  •  2.4  k~2 cm  2,  C m =  7.87  •  0.58  /zF/cm  2.  Six fibers studied in  0  #M 
nifedipine, 2 mM tetracaine: temperature =  4.4 •  0.1~  Ri =  365 •  5.1 f/cm, X =  2.2 -+ 0.2 
mm, r~ =  11,438  -+  1,449 k~//cm, diameter =  67.01  •  4.6 #m, r~ =  576  •  119 kf/cm, R  m  ~--- 
11.83  •  2.2 kf~ cm  *, C m =  8.0  +  0.73 #F/cm  ~. HU.A~IO  Charge Movement Components in Nifedipine  553 
The present  findings indicated a  sharper onset of inactivation beginning only at 
holding levels depolarized to -  70 mV in agreement with earlier reports (Hui, 1983; 
Huang, 1984).  Intact fibers also required considerably higher nifedipine concentra- 
tions (2.0 #M instead of 0.5 ~tM) to yield positive  effects. In the latter respect, the 
findings resemble those reports by Lamb (1986)  in cut mammalian muscle fibers. 
Alternatively, Csernoch et al. (1988) reported differences in effective pharmacologi- 
cal concentrations between amphibian preparations concerning tetracaine action. 
Nevertheless, some of the features in intact fibers facilitated the study of charge 
susceptible to voltage-dependent effects of nifedipine. Thus, studies of both inactiva- 
tion and membrane capacitance independently demonstrated partial charge inactiva- 
tion with a  -100  mV  to  -70  mV  shift in holding voltage at  the  same  (2  #M) 
nifedipine concentration within the same muscle fiber in contrast to the absence of 
such effects at lower or zero drug concentrations. However, capacitative properties 
in 0 or 0.5 ~M nifedipine were not influenced by shifts in holding voltage between 
-  100 mV and -  70 mV, which then assumed the steeper form resembling results in 
fully polarized fibers in 2 #M nifedipine. Higher concentrations (10 ~M) depressed 
the capacitance-voltage function and reduced available  charge, but small shifts in 
holding potential were now without further effect. 
This  particular  action  of nifedipine  appeared  to  selectively  involve  a  distinct 
component  of nonlinear charge,  rather  than  the  charge  as  a  whole.  First,  the 
capacitative contribution concerned was substantially more steeply voltage depen- 
dent than either the overall membrane capacitance preceding inactivaton, or the 
fraction  remaining  after  such  treatment.  Second,  the  voltage-dependent  block 
preferentially involved late charging transients (Adrian and Peres,  1979; Hui, 1983; 
Huang,  1987;  Huang and Peachey, 1989)  rather than reducing the charge move- 
ment uniformly through its time course. At the same time, one may emphasize that 
the steady-state criteria used to separate the tetracaine-sensitive (q,) charge leave it 
possible  that  q~  may include  early currents  overlapping in  time  course  with  qr 
charge.  Third,  nifedipine did not influence inactivation of qt~ charge, isolated by 
removing q, with tetracaine (Huang, 1981,  1982;  Vergara and Caputo, 1982;  Hui, 
1983).  In tetracaine-treated fibers,  small shifts in holding potential did not further 
reduce nonlinear charge even in the presence of nifedipine, nor did such conditions 
significantly influence  steady-state  capacitances  or  charging  currents  of  the  q0 
system. Thus, tetracaine obliterates the voltage-dependent block of intramembrane 
charge by nifedipine. 
The  above  observations  exclude  a  significant participation  of qt~  (tetracaine- 
resistant) charge from voltage-dependent nifedipine action. This leaves the charge 
concerned within the category of tetracaine-sensitive (q~) charge, while not directly 
indicating whether the  pharmacological species  are  exactly equivalent.  Thus,  the 
extent of tetracaine-induced block exceeded the voltage-dependent block by 2 /zM 
nifedipine. On the other hand, the prolonged depolarizations used were confined to 
the range -  100 mV to -  70 mV as the control data suggested that only within this 
range would any inhibition exclusively  reflect voltage-dependent pharmacological 
block.  It is  possible  that larger depolarization might have extended the block by 
nifedipine. Alternatively, some of these differences may parallel variations in the 
physiological  actions of these drugs. Both inhibit calcium currents (e.g,, Almers and 554  THE JOURNAL OF  GENERAL PHYSIOLOGY ￿9 VOLUME 96 ￿9 1990 
Palade,  1981).  However,  voltage-dependent  nifedipine  treatment  often  reduced 
rather  than  completely removed contractile  activation (Rakowski et al.,  1987) and 
A[Ca  2+] signals  (Rios and Brum, 1987) in amphibian muscle. It reduced, rather than 
abolished contractility, and then in only -50% of mammalian fibers studied (Lamb, 
1986). In contrast, tetracaine could fully abolish both calcium signals and contractile 
activation (Luttgau and Oefliker,  1968; Vergara and Caputo,  1982). This leaves it 
possible that even high concentrations of nifedipine,  particularly in fully polarized 
fibers, may not abolish the entire charge fraction related to excitation-contraction 
coupling,  resulting  in  persistent  contractile  activation under  such conditions  (Mc- 
Cleskey,  1985). 
In  any  event,  the  findings  here  demonstrate  a  charge  fraction  inhibited  by a 
combination of imposed depolarization  and nifedipine, which belongs to the cate- 
gory of tetracaine-sensitive (q~) rather than tetracaine-resistant  (qt~) charge. Such qv 
charge has a distinct sensitivity to test and holding potential (Adrian and Peres, 1979; 
Huang,  1981,  1982),  tetracaine  (Huang,  1981;  Hui,  1983),  and  lyotropic agents 
(Huang,  1986), and appears to be selectively localized to transverse tubular mem- 
brane (Adrian and Huang, 1984b;  Huang,  1987; Huang and Peachey, 1989). These 
parallels would be consistent with this charge fraction having a  causal relationship 
with excitation-contraction  coupling.  This could be through  offering an indepen- 
dent voltage-sensing transition  as part of q~ (Huang and Peachey,  1989), or as an 
end result of a reaction sequence that could involve the remaining intramembrane 
charge (Rios and Brum, 1987) or even the calcium ultimately released (Horowicz and 
Schneider,  1981; Huang, 1981; Csernoch et al.,  1989; Pizarro et al.,  1990). 
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